Research Papers: Gerotarget (Focus on Aging):
Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study
Metrics: PDF 1597 views | HTML 2564 views | ?
Paolo Giuseppe Limoli1, Celeste Limoli1, Enzo Maria Vingolo2, Sergio Zaccaria Scalinci3 and Marcella Nebbioso4
1 Low Vision Research Centre of Milan, Milan, Italy
2 Department of Ophthalmology, A. Fiorini Hospital, Terracina, Polo Pontino, Sapienza University of Rome, Rome, Italy
3 Departement of Ophthalmology, Glaucoma and Low Vision Study Center, University of Bologna, S. Orsola–Malpighi Hospital, Bologna, Italy
4 Department of Sense Organs, Faculty of Medicine and Odontology, Sapienza University of Rome, Rome, Italy
Marcella Nebbioso, email:
Keywords: age-related macular degeneration (AMD); cell autologous graft; growth factors (GFs); limoli retinal restoration technique (LRRT); suprachoroidal graft; Gerotarget
Received: April 15, 2016 Accepted: June 07, 2016 Published: July 06, 2016
Background: The aim of this research was to study the overall restoration effect on residual retinal cells through surgically grafted autologous cells onto the surrounding tissue, choroid and retina in order to produce a constant secretion of growth factors (GFs) in dry age-related macular degeneration (AMD) patients.
Results: 6 months after surgery, several values were statistically significant in the group with higher RTA. Also patient compliance analysis (PCA) in relation to functional change perception appeared to be very good.
Methods: Thirty-six eyes of 25 patients (range 64-84 years of age) affected by dry AMD were included in study, and divided in two groups by spectral domain-optical coherence tomography (SD-OCT): group A with retinal thickness average (RTA) less than 250 microns (µm) and group B with RTA equal to or more than 250 µm. Adipocytes, adipose-derived stem cells from the stromal-vascular fraction, and platelets from platelet-rich plasma were implanted in the suprachoroidal space. Particularly, the following parameters were evaluated: best corrected visual acuity (BCVA) for far and near distance, retinal thickness maps, scotopic and photopic electroretinogram (ERG), and microperimetry (MY). All statistical analyses were performed with STATA 14.0 (Collage Station, Texas, USA).
Conclusions: The available set of GFs allowed biological retinal neuroenhancement. After 6 months it improved visual performance (VP), but the increase was better if RTA recorded by OCT was higher, probably in relation to the presence of areas with greater cellularity.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.